Hashash Jana G, Picco Michael F, Farraye Francis A
Inflammatory Bowel Disease Center, Division of Gastroenterology, Mayo Clinic, Jacksonville, FL USA.
Curr Treat Options Gastroenterol. 2021;19(4):583-596. doi: 10.1007/s11938-021-00364-9. Epub 2021 Nov 22.
This review serves as a summary of healthcare maintenance items that should be addressed when managing patients with inflammatory bowel disease (IBD). This manuscript discusses vaccine-preventable illnesses, cancer prevention recommendations, and other screenings that are important to gastroenterologists and primary care physicians caring for patients with IBD.
Patients with IBD often require immunomodulator agents and/or biologics to induce and maintain disease remission which can increase the risk of developing several infections. Also, subsets of patients with IBD are at an increased risk for a number of malignancies including colon, cervical, and skin cancers.
Staying up-to-date with health care maintenance of patients with IBD is critical, especially given their increased risk for vaccine-preventable infections as well as comorbidities such as cancers, bone health, and mood disorders. Gastroenterologists and primary care physicians should familiarize themselves with the required screenings and vaccines that are recommended for adult patients with IBD, particularly those who are immunosuppressed.
本综述总结了在管理炎症性肠病（IBD）患者时应关注的医疗保健维护项目。本文讨论了疫苗可预防疾病、癌症预防建议以及其他对照顾IBD患者的胃肠病学家和初级保健医生很重要的筛查。
IBD患者通常需要免疫调节剂和/或生物制剂来诱导和维持疾病缓解，这可能增加发生多种感染的风险。此外，IBD患者的一些亚组患多种恶性肿瘤的风险增加，包括结肠癌、宫颈癌和皮肤癌。
及时了解IBD患者的医疗保健维护至关重要，特别是考虑到他们患疫苗可预防感染以及癌症、骨骼健康和情绪障碍等合并症的风险增加。胃肠病学家和初级保健医生应熟悉为成年IBD患者推荐的所需筛查和疫苗，尤其是那些免疫抑制患者。
